While in lung and colon cancer macroH2A1.1 loss is a marker of poor prognosis (22, 23), it is interesting that the opposite association exists for triple-negative breast cancer, where macroH2A1.1 expression is a marker of poor prognosis (21). This evidence concerns the gene MACROH2A1 and triple-negative breast carcinoma.